Histologic changes in type A chronic atrophic gastritis indicating increased risk of neuroendocrine tumor development: the predictive role of dysplastic and severely hyperplastic enterochromaffin-like cell lesions.
Details
Serval ID
serval:BIB_16AE590F7D3F
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Histologic changes in type A chronic atrophic gastritis indicating increased risk of neuroendocrine tumor development: the predictive role of dysplastic and severely hyperplastic enterochromaffin-like cell lesions.
Journal
Human Pathology
ISSN
1532-8392 (Electronic)
ISSN-L
0046-8177
Publication state
Published
Issued date
2013
Peer-reviewed
Oui
Volume
44
Number
9
Pages
1827-1837
Language
english
Notes
Publication types: Journal ArticlePublication Status: ppublish
Abstract
The role of putative preneoplastic enterochromaffin-like cell lesions, either hyperplastic or dysplastic, in the genesis of type 1 enterochromaffin-like cell neuroendocrine tumors associated with type A chronic atrophic gastritis, their actual neoplastic risk, and their precise histogenetic mechanism deserve further clarification by specific histopathologic studies coupled with patient follow-up. A total of 100 patients with severe type A chronic atrophic gastritis, enterochromaffin-like cell hyperplasia, and antral G-cell hyperplasia were endoscopically and histologically followed up for a median of 90.1 months (total of 9118 person-months). Preneoplastic enterochromaffin-like cell lesions and newly developed neuroendocrine tumors were investigated histologically and histochemically, in parallel with enterochromaffin-like cell lesions found in nontumor mucosa of another 32 well-characterized and previously reported type 1 neuroendocrine tumors. Both neuroendocrine and nonneuroendocrine mucosa changes were analyzed and statistically evaluated. During follow-up, 7 of 100 patients developed neuroendocrine tumors: 5 were in a group of 20 cases with previous enterochromaffin-like cell dysplasia and 2 were among 80 cases showing only enterochromaffin-like cell hyperplasia throughout the study (hazard ratio, 20.7; P < .001). The severity of enterochromaffin-like cell hyperplasia at first biopsy, with special reference to linear hyperplasia with 6 chains or more per linear millimeter, also increased the risk of neuroendocrine tumor development during follow-up (hazard ratio, 13.0; P < .001). Enterochromaffin-like cell microinvasive dysplastic lesions arising at the epithelial renewal zone level, in connection with immature proliferating mucous-neck cells, were found to be linked to early intramucosal neuroendocrine tumor histogenesis. Both enterochromaffin-like cell dysplasia and severe hyperplasia indicate increased risk of neuroendocrine tumor development in type A chronic atrophic gastritis with hypergastrinemia/G-cell hyperplasia.
Keywords
Comorbidity, Disease Progression, Endoscopy, Gastrointestinal, Enterochromaffin Cells/pathology, Follow-Up Studies, Gastric Mucosa/pathology, Gastritis, Atrophic/complications, Gastritis, Atrophic/mortality, Humans, Hyperplasia, Italy/epidemiology, Kaplan-Meier Estimate, Neuroendocrine Tumors/etiology, Neuroendocrine Tumors/mortality, Precancerous Conditions/pathology, Prognosis, Pyloric Antrum/pathology, Risk Factors, Stomach Neoplasms/complications, Stomach Neoplasms/mortality, Survival Rate
Pubmed
Web of science
Create date
06/09/2016 12:57
Last modification date
20/08/2019 12:46